Retail claims transitioning from US Script pharmacy networks to pharmacy networks contracted and managed by CVS/caremark for members enrolled in Sunshine Health will continue to process through US Script.

Additional suppliers have not yet received FDA approval to launch Generic Crestor^® (rosuvastatin), so there is a delay on this product going multi-player.

On Monday, July 11, Edenbridge launched the generic equivalent of Edecrin® (ethacrynic). The Edenbridge item will be added to the OneStop program in the A* position with visibility in McKesson Connect July 9. Estimated brand sales of Edecrin® are $89M.

This notification is provided to you pursuant to Texas Labor Code Section 408.0281(d) "Notification to Health Care Provider" and contains the information we may elect to provide to any person, other than an injured employee, to whom access has been provided to the contractual fee arrangement that National Pharmaceutical Service (NPS) has with you. This applies to contractual fee arrangements for services through the NPS network at rates inconsistent with the Texas workers’ compensation pharmacy fee guidelines. National Pharmaceutical Services is contracted with the following Texas Carriers for the time periods listed below allowing each access to the contractual fee arrangement with you:

On June 28, 2016, Trividia Health announced a recall of certain lots of TRUEread, TRUEbalance, TRUEtrack, and TRUEtest blood glucose test strips because of open test strip vials within the sealed test strip vial boxes.